Genopathy
Gene-Disorder Association · Article
Gene
CYP2A6
Cytochrome P450 Family 2 Subfamily A Member 6
Disorder
Tobacco Addiction
First reported 1999
Supporting publications 7
Key publication · gene–disorder Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.FEBS letters · 1999
Key publication · disorder Lung cancer and the tobacco smoking habit.Industrial medicine & surgery · 1954
Manually curatedApproved treatment annotated
Association Review

In brief

The association between CYP2A6 (Cytochrome P450 Family 2 Subfamily A Member 6) and Tobacco Addiction is a manually-curated gene–disease association, with its 2 contributing sources — 1 of them expert-curated — recording a known molecular basis and a susceptibility locus.

Sources 2
Clinical variants 0
Symptoms 1
Compounds 1
Trials 119of 322 via CYP2A6 compounds
Publications 7
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CYP2A6

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Tobacco Addiction

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

322 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

7 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

12 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access